Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B

OBJECTIVES: Suppressor of cytokine signaling 3, myxovirus resistance protein and osteopontin gene polymorphisms may influence the therapeutic response in patients with chronic hepatitis C, and an association with IL28 might increase the power to predict sustained virologic response. Our aims were to...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelo, Ana Luiza Dias, Cavalcante, Lourianne Nascimento, Abe-Sandes, Kiyoko, Machado, Taísa Bonfim, Lemaire, Denise Carneiro, Malta, Fernanda, Pinho, João Renato, Lyra, Luiz Guilherme Costa, Lyra, Andre Castro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798553/
https://www.ncbi.nlm.nih.gov/pubmed/24212839
http://dx.doi.org/10.6061/clinics/2013(10)06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798553/
https://www.ncbi.nlm.nih.gov/pubmed/24212839
http://dx.doi.org/10.6061/clinics/2013(10)06

Ejemplares similares